BARDA Industry Day 2012: Contracting for Countermeasures


Back

BARDA Industry Day 2012

Day 1 - Monday, December 10, 2012

icon Nicole Lurie, MD: Keynote Address - MCM State of Affairs
icon Carol D. Linden, Ph.D.: 2012 HHS PHEMCE Strategy and Implementation Plan
icon Michael Kurilla, M.D., Ph.D.: MCM Development and Manufacturing NIH Perspectives
icon Gerald R. Kovacs, Ph.D.: BARDA CBRN Medical Countermeasures Portfolio
icon Anthony Macaluso, Ph.D.: Chemical Biological Medical Systems
icon Luciana Borio, M.D.: Pathways for Medical Countermeasure Development and Use
icon Daniel Sosin, MD, MPH, FACP: 2012 PHEMCE Strategy Goal 3
icon Richard L Gorman, MD: PHEMCE Partner Efforts in Support of Goal 4 of the 2012 PHEMCE Strategy
icon Louise Pitt, Ph.D.: Animal Models and Efficacy Studies
icon Judith A. Hewitt, Ph.D.: Animal Model Resources for MCM Development
icon Thomas M. Dreier, Ph.D.: BARDA Nonclinical Development Network
icon Dr. Robert Johnson: Clinical Resources for Microbiology and Infectious Diseases Research Community
icon Jo Ellen Schweinle, MD: BARDA Division of Clinical Studies
icon Dr. Alan Liss: FDA's Medical Countermeasures Initiative (MCMi)
icon Debra A. Yeskey Pharm.D.: Regulatory and Quality Affairs
icon Mike Angelastro: Core Service Support for MCM Advanced Development and Manufacturing
icon Rosemarie Aurigemma, Ph.D.: Development of Antimicrobials and Broad-Spectrum Activity: Antibiotics
icon Joe Larsen, Ph.D.: Broad Spectrum Antimicrobials (BSA)
icon Michael Wathen: Improving Pipeline for the Development of Influenza Antivirals
icon Judith Wolfe Laney, Ph.D.: Chemical MCM Development at BARDA
icon Ronald G. Manning, Ph.D.: Repurposing of approved products for use against public health threats
icon Michael Shaw, M.D.: Influenza Diagnostics Update
icon Rodney Wallace: CBRN Diagnostics Overview
icon Melanie Choe, Ph.D.: Respiratory Devices for Medical Countermeasures
icon Lewis Radonovich, M.D.: An Ideal Environment for Health Care Field Testing
icon Jonathan Yewdell, M.D., Ph.D.: Influenza Adrift - Rethinking Influenza Vaccination
icon Alan Goldberg: Host Directed Therapeutics and Immunomodulators
icon Traci Mondoro: Cellular Therapies for Use in Public Health Emergencies
icon Anton Simeonov: The NCATS Pharmaceutical Collection-Potential Use for Rapid Repurposing Against New/Emerging Threats

Day 2 - Tuesday, December 11, 2012

icon Welcome: Day 2 - BARDA Industry Day - Washington, DC Contracting for Countermeasures, Introduction
icon You Are Here Map (Part 1)
icon Walkthrough: Requirements Document Example
icon Cameron Hernandez: Market Research and Getting Started
magnifying glass Walkthrough: Market Research Examples
icon Dr. Adam Clark: TechWatch
icon Susan Cortes - Shrank: Broad Agency Announcements (BAA), Request for Proposals (RFP)and Their Differences
icon Walkthrough: Solicitation Outline Examples
icon Walkthrough: Recap 1
icon You Are Here Map (Part 2)
icon Malda Brown: Small Business 101
icon Tasha McMillian: White Paper Review Process & Invite / Do-Not-Invite Letters
icon Eric Steinberg: Walkthrough: Invite / Do-Not-Invite Letter Examples
icon Eric Steinberg: Contract Types
icon Contract Type Matrix
icon Walkthrough: Contract Table of Contents Example
icon Jolinda Summers: Business Tool Kit
icon Jason Vettickal: Earned Value Management
icon Brooke Bernold: Mock T.E.P.
icon Walkthrough: Recap 2
icon You Are Here Map (Part 3)
icon Matthew Rose: Introduction to Negotiations
icon Walkthrough: Recap 3
icon Francine Hemphill: Debriefing
icon Walkthrough: Recap 4
icon You Are Here Map (Part 4)
icon Susan Cortes-Shrank: Contracting Officer's Authorization (COA)
icon Walkthrough: COA Example
icon Forest Crumpler: Show Me the Money™: Invoices in Brief
icon Invoicing Pitfalls
icon Walkthrough: Invoice Example
icon Brendan Miller: Contract Modifications
icon Jolinda Summers: In Process Reviews (IPR)
icon Jolinda Summers: Mock IPR
icon Barbara Orlando: Division Of Grants
icon Andre Early: Commercial Items
icon Walkthrough: Recap 5
icon ASPR Acronym
Website Refresh - www.medicalcountermeasures.gov is pleased to announce a phased launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience. Over the next several months you will see differences throughout the site while we continue implementing updates. Thank you for your understanding and please let us know if you have any questions: techwatchinbox@hhs.gov